Instructions for Rigevidon (Levonorgestrel, Ethinylestradiol) pills
English Product Name
Rigevidon®
Release Form
Enveloped tablets
Description:
Pills coated with white skin, round, double-convex.
1 table
Levonorgestrel 0.15 mg
ethinyl estradiol 0.03 mg
Auxiliaries: silicon colloid dioxide,
magnesium stearate,
talc,
cornstarch,
lactose monohydrate.
Envelope composition:
saccharose,
talc,
calcium carbonate,
titanium dioxide,
copovidon,
macrogol 6000,
silicon colloidal dioxide,
povidon K-30, carmelosis triumph.
21 pcs. - blisters (1) - cardboard packs with blister storage case.
21 pcs. - blisters (3) - cardboard packs with blister storage case.
ATX codes
G03AA07 Levonorgestrel and estrogen
Clinical and pharmacological groups / Group affiliation
Monophase oral contraceptive
Active substance
- ethinyl estradiol
- Levonorgestrel
Pharmacotherapeutic group:
Contraceptive compound (estrogen + gestagen)
Storage conditions Rigevidon:
The drug should be stored away from children at a temperature not exceeding 25°C.
Expiry Date
Shelf life - 3 years. Do not use after expiry of the shelf life specified on the package.
Indications Rigevidon:
oral contraception;
functional disturbances of the menstrual cycle (including an organic-cause dismenorrhea, dysfunctional metrorrhagia);
premenstrual syndrome.
Method of application, course and dosage:
The drug is taken inwards without chewing and drinking a small amount of liquid.
If hormonal contraception was not performed during the previous menstrual cycle, Rigevidon is taken as ® the first day of menstruation with 1 tablet every day for 21 days at the same time of day. This is followed by a 7-day break during which menstrual bleeding occurs. The next 21-day cycle of tablets from a new package containing 21 tablets should start the day after the second-day break, i.e. on the 8th day, even if the bleeding has not stopped. Thus, the start of taking the drug from each new package falls on the same day of the week.
Kidney disorders
Care is needed when prescribing the drug to patients with kidney disorders.
Application for liver function disorders
The use in cases of severe liver diseases (including congenital hyperbilirubinemia - Gilber, Dubin-Johnson and Rotor syndromes) is contraindicated; liver tumors).
Terms of sale
The drug is prescription.
Use in older patients
Contraindicated in the age over 40.
- Nosology Rigevidon (ICD codes)
- N93
- Other abnormal bleeding from the uterus and vagina
- N94.3
- Premenstrual stress syndrome
- N94.6
- Dismenorium unspecified
- Z30.0
- General advice and advice on contraception
Pharmacological effect Levonorgestrel:
Combined monophase oral estrogen-gestagenic contraceptive drug.
When taken in, it oppresses the pituitary secretion of gonadotropic hormones. The contractionary effect is associated with several mechanisms. As a gestagenic component (progestin) contains a derivative of 19-nortestosterone - Levonorgestrel, which exceeds in activity the yellow body hormone progesterone (and the synthetic analog of the last - pregnin), receptors without preliminary metabolic transformation. Ethinyl estradiol is an estrogen component.
